This tool was created to help providers understand the benefits and risks of SGLT2 inhibitors for patients with and without diabetes.
Please enter all required patient information.
Made by Dr. Michael Fralick, Michelle Gyenes, Jason Moggridge, and Andy Zhao © 2022. Funded by BioTalent Canada and Sinai Health Department of Medicine Research Fund.
Version 1.5.0Provide Feedback